254 related articles for article (PubMed ID: 25353182)
1. The antidiabetic hormone glucagon-like peptide-1 induces formation of new elastic fibers in human cardiac fibroblasts after cross-activation of IGF-IR.
Qa'aty N; Wang Y; Wang A; Mao S; Vincent M; Husain M; Hinek A
Endocrinology; 2015 Jan; 156(1):90-102. PubMed ID: 25353182
[TBL] [Abstract][Full Text] [Related]
2. Synthetic ligands of the elastin receptor induce elastogenesis in human dermal fibroblasts via activation of their IGF-1 receptors.
Qa'aty N; Vincent M; Wang Y; Wang A; Mitts TF; Hinek A
J Dermatol Sci; 2015 Dec; 80(3):175-85. PubMed ID: 26475432
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner.
Bunda S; Liu P; Wang Y; Liu K; Hinek A
Am J Pathol; 2007 Sep; 171(3):809-19. PubMed ID: 17724138
[TBL] [Abstract][Full Text] [Related]
4. Sodium L-ascorbate enhances elastic fibers deposition by fibroblasts from normal and pathologic human skin.
Hinek A; Kim HJ; Wang Y; Wang A; Mitts TF
J Dermatol Sci; 2014 Sep; 75(3):173-82. PubMed ID: 25015208
[TBL] [Abstract][Full Text] [Related]
5. Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system.
Vergès B; Bonnard C; Renard E
Diabetes Metab; 2011 Dec; 37(6):477-88. PubMed ID: 21871831
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
Widmann C; Bürki E; Dolci W; Thorens B
Mol Pharmacol; 1994 May; 45(5):1029-35. PubMed ID: 8190093
[TBL] [Abstract][Full Text] [Related]
7. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
Dubé PE; Forse CL; Bahrami J; Brubaker PL
Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
[TBL] [Abstract][Full Text] [Related]
8. Role of glucagon-like peptide-1 and its agonists on early prevention of cardiac remodeling in type 1 diabetic rat hearts.
Barakat GM; Nuwayri-Salti N; Kadi LN; Bitar KM; Al-Jaroudi WA; Bikhazi AB
Gen Physiol Biophys; 2011 Mar; 30(1):34-44. PubMed ID: 21460410
[TBL] [Abstract][Full Text] [Related]
9. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
Nauck MA
Horm Metab Res; 2004; 36(11-12):852-8. PubMed ID: 15655719
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic digest derived from bovine Ligamentum Nuchae stimulates deposition of new elastin-enriched matrix in cultures and transplants of human dermal fibroblasts.
Hinek A; Wang Y; Liu K; Mitts TF; Jimenez F
J Dermatol Sci; 2005 Sep; 39(3):155-66. PubMed ID: 15925490
[TBL] [Abstract][Full Text] [Related]
12. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
Otto Buczkowska E; Dworzecki T
Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
Ban K; Noyan-Ashraf MH; Hoefer J; Bolz SS; Drucker DJ; Husain M
Circulation; 2008 May; 117(18):2340-50. PubMed ID: 18427132
[TBL] [Abstract][Full Text] [Related]
14. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
[TBL] [Abstract][Full Text] [Related]
15. Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts.
Zhao T; Parikh P; Bhashyam S; Bolukoglu H; Poornima I; Shen YT; Shannon RP
J Pharmacol Exp Ther; 2006 Jun; 317(3):1106-13. PubMed ID: 16489128
[TBL] [Abstract][Full Text] [Related]
16. Exogenous expression of glucagon-like peptide 1 receptor and human insulin in AtT-20 corticotrophs confers cAMP-mediated gene transcription and insulin secretion.
Sidhu KK; Fowkes RC; Skelly RH; Burrin JM
J Endocrinol; 2005 Dec; 187(3):419-27. PubMed ID: 16423821
[TBL] [Abstract][Full Text] [Related]
17. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
[TBL] [Abstract][Full Text] [Related]
18. Non-insulin injectable treatments (glucagon-like peptide-1 and its analogs) and cardiovascular disease.
Lebovitz HE; Banerji MA
Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S43-50. PubMed ID: 22650224
[TBL] [Abstract][Full Text] [Related]
19. DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.
Riedel MJ; Gaddy DF; Asadi A; Robbins PD; Kieffer TJ
Gene Ther; 2010 Feb; 17(2):171-80. PubMed ID: 19865180
[TBL] [Abstract][Full Text] [Related]
20. New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1).
Yu Z; Jin T
Cell Signal; 2010 Jan; 22(1):1-8. PubMed ID: 19772917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
